INCH
发表于 2025-3-23 12:24:26
http://reply.papertrans.cn/71/7036/703512/703512_11.png
CHAFE
发表于 2025-3-23 15:56:22
http://reply.papertrans.cn/71/7036/703512/703512_12.png
欲望
发表于 2025-3-23 20:06:58
Oral Anticoagulants in Stable Moderate Chronic Kidney Disease function bordering the recommended functional criteria for dose adjustments complicates dose selection and safe long-term use. Increased monitoring and assessment of the benefits and risks of direct oral anticoagulation therapy are required to mitigate poor outcomes resulting from clinical status c
改良
发表于 2025-3-24 01:50:40
http://reply.papertrans.cn/71/7036/703512/703512_14.png
Relinquish
发表于 2025-3-24 02:35:51
http://reply.papertrans.cn/71/7036/703512/703512_15.png
IOTA
发表于 2025-3-24 06:41:51
http://reply.papertrans.cn/71/7036/703512/703512_16.png
他日关税重重
发表于 2025-3-24 13:00:08
http://reply.papertrans.cn/71/7036/703512/703512_17.png
Constituent
发表于 2025-3-24 16:14:02
Patient with Concomitant Aortic Valve Stenosisin atrial fibrillation. If anticoagulation is indicated in a patient with atrial fibrillation based on presence of other traditional atrial fibrillation related stroke risk factors either warfarin or any of the nonwarfarin oral anticoagulants are reasonable choices.
MURKY
发表于 2025-3-24 22:03:13
Introductiont and route of administration, and thus lack of patient acceptance. Fortunately, we have entered an era where several viable oral anticoagulant alternatives exist. These direct oral anticoagulants have much more predictable dose-response profiles thus eliminating the need for frequent monitoring. In
GRATE
发表于 2025-3-24 23:29:45
http://reply.papertrans.cn/71/7036/703512/703512_20.png